Background and Objectives
As a chronic infectious disease, periodontitis could lead to tooth and bone loss. Lowâintensity pulsed ultrasound (LIPUS) is a safe, noninvasive treatment method to effectively inhibit inflammation and promote bone differentiation. However, the application of LIPUS in curing periodontitis is still rare. Our study aimed to explore the ability of LIPUS to inhibit inflammatory factors and promote the osteogenic differentiation capacity of human periodontal ligament cells (hPDLCs), and its underlying mechanism.
Material and Methods
Human periodontal ligament cells were obtained and cultured from the premolar tissue samples for experiments. First, hPDLCs were treated for 24 hours using lipopolysaccharide (LPS) and then exposed to LIPUS (10 mW/cm2, 30 mW/cm2, 60 mW/cm2, and 90 mW/cm2) to determine the appropriate intensity to inhibit expression of the inflammatory factors interleukinâ6 (ILâ6) and interleukinâ8 (ILâ8) expression. The expression of ILâ6 and ILâ8 was detected by realâtime PCR and enzymeâlinked immunosorbent assay. The safety of the most appropriate intensity of LIPUS was tested by a cell counting kit 8 test and an apoptosis assay. Then, LPSâinduced hPDLCs were treated in osteogenic medium for 7â21 days with or without LIPUS (90 mW/cm2, 30 min/d) stimulation. The osteogenic genes RUNX2, OPN, OSX, and OCN were measured by realâtime PCR. Additionally, osteogenic differentiation capacity was determined using alkaline phosphatase (ALP) staining, ALP activity analysis, and Alizarin red staining. The activity of the nuclear factorâkappa B (NFâÎșB) signaling pathway was determined by western blotting, realâtime PCR, immunofluorescence, and pathway blockade assays.
Results
Lipopolysaccharide significantly upregulated the production and gene expression of ILâ6 and ILâ8, while LIPUS stimulation significantly inhibited ILâ6 and ILâ8 expression in an intensityâdependent manner. LIPUS (90 mW/cm2) was chosen as the most appropriate intensity, and there was no detrimental influence on cell proliferation and status with or without osteogenic medium. In addition, consecutive stimulation with LIPUS (90 mW/cm2) for 30 min/d for 7 days could also inhibit ILâ6 and ILâ8 gene expression, upregulate the expression of the osteogenesisârelated genes RUNX2, OPN, OSX, and OCN, and promote osteogenic differentiation capacity in osteogenic medium in inflamed hPDLCs. The NFâÎșB signaling pathway was inhibited with LIPUS (90 mW/cm2) via inhibition of the phosphorylation of IÎșBα and the translocation of p65 into the nucleus in inflamed hPDLCs. Additional investigations of the NFâÎșB inhibitor, BAY 11â7082, revealed that LIPUS (90 mW/cm2) acted similarly to BAY 11â7802 to inhibit the NFâÎșB signaling pathway and increase osteogenesisârelated genes and promote the osteogenic differentiation capacity of inflamed hPDLCs.
Conclusion
Lowâintensity pulsed ultrasound (90 mW/cm2) stimulation could be a safe method to inhibit ILâ6 and ILâ8 in hPDLCs by inhibiting the NFâÎșB signaling pathway. The effect of LIPUS (90 mW...